A CEO's message: From humble beginnings, our company has grown up

All grown up

David Gow, right, with Houston Astros president Reid Ryan. Photo by Michele Lee Sparks/Archer Sparks

Last week, the son of a good friend came up to our office. It had been a couple of years since I had seen him, so I still envisioned that he would be an 18-year-old high-school kid. But, when he walked in the room, I did a double-take, as he was now a mature young man. The kid had grown up, and he was standing before me ready to talk business.

In some ways, the story illustrates Gow Media. Sometimes I come across people who will ask me: "How is 1560-The-Game doing?"

We are not that young kid anymore. We have matured from a sports radio venture to a multi-platform media company. And we, too, stand before you ready to talk business.

Here's the story of that grown-up company, with the following highlights:

  • ESPN 97.5 FM: Dominant sports ratings.
  • CultureMap: A large wave of growth.
  • SportsMap: New content and record traffic.
  • InnovationMap: A banner start.
  • SB Nation Radio: Elimination of a competitor.
  • The Team: New faces in leadership roles.

ESPN 97.5 FM

A year ago, we secured the No. 1 sports ratings position. This past quarter, we dominated. In the latest Nielsen book, we have the top four sports shows in the city, and five of the top six. The top four: (No. 1) John and Lance; (No. 2) The Blitz; (No. 3) The Usual Suspects; and (No. 4) The Charlie Pallilo Show. In morning and afternoon drive times, our ratings share was higher than our two competitors combined. And more good news: this quarter the Houston Press announced "The Best Radio Station" in Houston. The winner: ESPN 97.5FM.

CultureMap

Last week, more than 1,000 people in Houston turned out for our Tastemakers event, which sold out for the second year in a row. It is an amazing sight to see hundreds of folks line up early at the door. The turnout embodied the growth of CultureMap, where online traffic is soaring. Our Houston editorial team of Steven Devadanam, Eric Sandler, Ken Hoffman and others is on a roll. For that matter, the same is true of our teams statewide. We are experiencing double-digit growth year-over-year, yielding a very large and loyal following.

SportsMap

Our deep pool of sports experts has led to record traffic levels. One fun feature: We get to try new combinations such as videos featuring Raheel with AJ and Granato; Lance paired with AJ; Faour and Pallilo. Other must-see videos include Charlie Pallilo and Joel Blank (aka "one-take-Jake"). And we continue to get great written contributions from Barry Laminack, Joshua Jordan, Jermaine Every, Cody Stoots, Jerry Bo and, of course, SportsMap editor Fred Faour.

InnovationMap

Due to the collective efforts of many, Houston is experiencing a great wave of innovation. And now the city has a media outlet to tell the stories. Launched late last year, and backed by blue-chip sponsors, InnovationMap is off to a great start.

When we were planning the site, we were continually asked: who would be the editor? We found a good answer: Natalie Harms, whose fingerprints are all over the site. Last week Natalie was honored by AAF Houston, given the "Rising Star" award.

SB Nation Radio

In this business where we provide sports shows and updates for other stations across the country, we have faced a very competitive landscape the past four years. Finally, in January one of our competitors, NBC Sports Radio, withdrew from the market — enabling new growth and increasing our reach. Our SB Nation Radio Network is now heard on 600 radio stations across the country.

The Team

This has been an exciting season of growth for our people also.In the past quarter, we promoted Josh Jordan to assistant editor of SportsMap; Tyler Scott became assistant programming director. And, most notably, we tapped AJ Hoffman to become program director for 97.5 FM.

Most everyone knows Fred and AJ as leading show hosts, but they are proving to be far more. As Editor of SportsMap for the past 18 months, Fred has been a catalyst for our growth and success online. With AJ, we are tapping into his natural programming instincts and leadership. I have enjoyed watching their talents extend beyond the show and into management.

Another double-take

Let's give sage Ken Hoffman the last word. Some may recall that Ken was with us for a short while in the early 1560-The-Game days. Two years ago, he returned to write for CultureMap — so he has some perspective, having seen both our youth and maturity.

The other day, he wandered into my office. Looking at Gow Media, it appears Ken had done a double-take. He declared: "I have something to tell you. You have the best group of people and talent now. You really do. This is different than before. You are a real grown-up company now."

------

David Gow is CEO of Gow Media, which owns ESPN 97.5 FM, CultureMap, SportsMap, InnovationMap, and SB Nation Radio. He is also host of The Boss and The Gloss on SB Nation Radio.

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

NASA unveils Artemis III astronauts at Johnson Space Center in Houston

To the moon

NASA on Tuesday, June 9, revealed the crew for its Artemis III mission, the next step in the space agency's plan to eventually land astronauts on the moon.

The announcement came two months after Artemis II's record-breaking trip around the moon that surpassed the distance record of Apollo 13.

NASA's Randy Bresnik, Frank Rubio, Andre Douglas and the European Space Agency's Luca Parmitano won't fly to the moon or land on the surface. Instead, they’ll orbit Earth while practicing docking their Orion capsule with two lunar landers.

“To the Artemis III crew, we wish you Godspeed on the journey ahead,” said NASA administrator Jared Isaacman.

Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are racing to deliver the lunar landers. The two-week demo is targeted for 2027. Blue Origin suffered a recent setback when its massive rocket exploded during an engine-firing test on the launch pad in Florida, shaking nearby homes and illuminating the sky with an orange fireball.

NASA's Jeremy Parsons said the setback is a learning opportunity and that the space agency is confident Blue Origin's rocket will be ready in time.

NASA's Artemis program aims to return astronauts to the moon's surface for the first time since the 1970s. A recent revamp of the program announced by Isaacman aims to fast-track it similarly to the Apollo era, adding the upcoming spaceflight around Earth before eyeing a lunar landing in 2028.

“We are certainly humbled as a crew to be able to be your crew that executes this Artemis III mission in space,” said Bresnik, Artemis III commander.

Added Douglas, mission specialist: “My brain — it is going a mile a minute right now. But my heart, it is so warm. It is so full."

In May, NASA awarded hundreds of millions of dollars in contracts to four companies, including Blue Origin, to build landers, rovers and drones for a future moon base. Isaacman said the goal of the moon base is to lay the foundation for a Mars expedition.

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

View All Listings